Although the precise mechanism by which COX-2 influences cancer development and progression in NPC remains unclear, this study highlights COX-2 expression’s potential as an indicator of cancer progression that can contribute to assessment of prognosis and treatment decisions and the therapeutic potential of COX-2 inhibitors in treatment of NPC. This evidence concerns the gene PTGS2 and cancer.